• Nenhum resultado encontrado

Rev. Bras. Reumatol. vol.56 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Reumatol. vol.56 número2"

Copied!
4
0
0

Texto

(1)

r e v b r a s r e u m a t o l . 2016;56(2):181–184

w w w . r e u m a t o l o g i a . c o m . b r

REVISTA

BRASILEIRA

DE

REUMATOLOGIA

Case

report

Acute

acalculous

cholecystitis

in

systemic

lupus

erythematosus:

a

rare

initial

manifestation

Valdano

Manuel

a,∗

,

Gertrudes

Maria

Pedro

b

,

Lemuel

Bornelli

Cordeiro

a

,

Sandra

Maria

da

Rocha

Neto

de

Miranda

a

aEducationOffice,Post-GraduationandResearch,ClínicaGirassol,Luanda,Angola

bDepartmentofInternalMedicine,ClínicaGirassol,Luanda,Angola

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received20December2013 Accepted26March2014 Availableonline25October2014

Keywords:

Systemiclupuserythematosus Acuteacalculouscholecystitis Abdominalcomputedtomography Initialmanifestation

a

b

s

t

r

a

c

t

Acuteacalculouscholecystitisisaveryraregastrointestinalmanifestationinsystemiclupus erythematosusandbecomesrarerasaninitialmanifestation.Thereareonlytwocases reported.Theauthorsreporta20-year-oldblackwomanthatpresentedacuteacalculous cholecystitisrevealedbyabdominalcomputedtomography.Duringhospitalization,shewas diagnosedsystemiclupuserythematosus.Conservativetreatmentwithantibioticswas per-formedwithcompleteremissionofthesymptoms.Corticosteroidwasstartedinambulatory. Cholecystectomyhasbeenthetreatmentofchoiceinacuteacalculouscholecystitisasa complicationofsystemiclupuserythematosus.Thepatientrespondedwelltoconservative treatment,andsurgerywasnotrequired.Thiscaseisuniqueinthewaythatcorticosteroid wasstartedinambulatorycare.Weshouldnotforgetthattheacuteacalculouscholecystitis canbetheinitialpresentationofsystemiclupuserythematosusalthoughitsoccurrenceis veryrare.Conservativetreatmentshouldbeconsidered.Abdominalcomputedtomography wasadeterminantexamforbetterassessmentofacuteacalculouscholecystitis.

©2013ElsevierEditoraLtda.Allrightsreserved.

Colecistite

aguda

acalculosa

no

lúpus

eritematoso

sistêmico:

uma

manifestac¸ão

inicial

rara

Palavras-chave:

Lúpuseritematososistêmico Colecistiteagudaacalculosa Tomografiacomputadorizadado abdome

Manifestac¸ãoinicial

r

e

s

u

m

o

Acolecistiteagudaacalculosaéumamanifestac¸ãogastrointestinalraranolúpus eritem-atoso sistêmicoe ainda mais rara como manifestac¸ão inicial. Foramdescritos apenas doiscasosatéomomento.Osautoresrelatamocasodeumamulhernegrade20anos, com quadrode colecistiteaguda acalculosa reveladapelatomografiacomputadorizada do abdome. Durantea hospitalizac¸ão, a paciente foi diagnosticada com lúpus eritem-atososistêmico.Houveremissãocompletadossintomasapóstratamentoconservadorcom

ThestudywasoriginatedatClínicaGirassol,Luanda,Angola.

Correspondingauthor.

E-mail:valdanympub@gmail.com(V.Manuel).

http://dx.doi.org/10.1016/j.rbre.2014.03.027

(2)

182

rev bras reumatol.2016;56(2):181–184

antibióticos.Iniciou-setratamentocomcorticosteroidesnoambulatório.Emboraa cole-cistectomiasejaotratamentodeescolhaemcasosdecolecistiteagudaacalculosacomo complicac¸ãodolúpuseritematososistêmico,apacienterespondeubemaotratamento con-servador;logo,acirurgianãofoinecessária.Estecasoéúnicoemrazãodomodocomo ocorticosteroidefoiiniciadonoatendimentoambulatorial.Éimportantelembrarquea colecistiteagudaacalculosapodeseramanifestac¸ãoinicialdolúpuseritematososistêmico, emborasuaocorrênciasejarara.Deve-seconsiderararealizac¸ãodetratamento conser-vador.Atomografiacomputadorizadadoabdomefoideterminante paraquefossefeita umamelhoravaliac¸ãodacolecistiteagudaacalculosa.

©2013ElsevierEditoraLtda.Todososdireitosreservados.

Introduction

Systemiclupuserythematosus(SLE)isanautoimmune dis-ease found predominantly in female gender1–3 in which

almostallorgans canbeinvolvedwithwide rangeof clini-calmanifestations.Gastrointestinalmanifestationisusually mild, but gallbladder involvementis an uncommon event. Acuteacalculouscholecystitis(AAC)isveryrareasa compli-cationofSLEandbecomesrarerasaninitialpresentation.1–9

SeveralcasesofAACasacomplicationofSLEwerereported; nevertheless only two cases have been reported as initial manifestation.5,9

Case

report

A 20-year-old black woman with history ofmigratory pol-yarthralgia was admitted with fever, nausea and vomit, acute abdominal pain in the right upper quadrant and referred loss of appetite. Physical examination evidenced febrile (38.6◦C), tachycardia (102 beats per minute),

dehy-dratedandsubictericmucousmembranes.Abdominalpain intherightupperquadrantwithhepatomegalyof8cmbelow thecostalmarginwasfound.Cardiacauscultation,revealed agrade-II/VIprotosystolicmurmurinall cardiacfocus. Ini-tiallaboratorydatashowedhemoglobin7.6g/dL,leucocytes 3300/L, albumin 2.2g/dL, alanine aminotransferase 86U/L, aspartateaminotransferase127U/L,totalbilirubin1.8mg/dL; lactatedehydrogenase1719U/Landtestforplasmodium neg-ative. Abdominal ultrasound confirmed hepatomegaly and revealedsplenomegaly,gallbladderslightlydistendedwithout wallthickening.During hospitalization,the patientevolved withretrosternalpain,orthopnea,surfeitsensation,increased pain in the right upper quadrant, nausea, vomiting, diar-rheaand fever. Pulmonary auscultation revealed abolished in both bases. Cardiac auscultation was the same. The abdomenwas distended withhepatomegaly of8cm below the right costal margin; liquid wave signal and murphy

werepresent.Lowerlimbspresentedmalleolaredema.The main laboratory findings are shown (Table 1). Teleradiog-raphy of chest showed bilateral pleural effusion of small volume. Echocardiography revealed pericardial effusion of 1.5cm.Abdominalcomputedtomographyrevealedincreased wall thickness without any evidence of stone and edema aroundthegallbladder(Fig.1),andconfirmedsplenomegaly,

hepatomegaly andascites. Basedonthephysical examina-tion,laboratoryandimagefindings,adiagnosisofinaugural systemiclupuserythematosustriggeredbyacuteacalculous cholecystitis was established. The patient initiated treat-ment with ceftriaxone and metronidazole, furosemide and albumin. Within10 days, therewas complete remissionof symptoms. The corticosteroid was initiated in ambulatory of rheumatology.Surgical interventionwas not performed. Accordingtotherheumatologists’feedback,shelookedwell and did not have any symptoms until four months after discharge.

Table1–Laboratoryfindingsduringadmissioncourse.

Exam Results Referencevalues

TestforPlasmodium Negative Negative Hemoglobin 6.9g/dL 11.5–15.5 Leukocytes 3.2×109/L 04–11 Platelets 342×109/L 150–400 Totalproteins 5.2mg/dL 6.5–8.1 Proteinuria-24h 174mg/dia <150 Albumin 2.3mg/dL 3.5–5.0

ALT 80U/L <40

AST 112U/L <40

LDH 1557U/L 230–460

Alkalinephosphatase 155U/L 32–92

GGT 256U/L <50

Creatinine 0.4mg/dL 0.6–1.3

Urea 4mg/dL 0.8–26

Amylase 28U/L 36–128

Anti-HBs 0.44S/CO <0.90 Anti-HCV 0.8S/CO <0.9 Toxoplasmosis 0.2S/CO <0.8

ANAa 6IU/mL >1.1positive

Anti-dsDNAa 80IU/mL >60positive

C3a 45.2mg/dL 79–152

C4a 7.1mg/dL 16–38

AnticardiolipinIgMa 7.9UMPL/mL 0.0–7.0

Anti-␤2glycoprotein1IgMa 12.1UMPL/mL 0.0–5.0

Anti-␤2glycoprotein1IgGa 5.5UGPL/mL 0.0–5.0

Smoothmuscleantibodya 1:80 <1:20

ALT,alanineaminotransferase;AST,aspartateaminotransferase; LDH, lactatedehydrogenase;GGT, gamma-glutamyltransferase; ANA,antinuclearantibody.

(3)

rev bras reumatol.2016;56(2):181–184

183

Fig.1–AbdominalCTshowgallbladderwallthickness withoutstonewithedemaaround(arrow).

Discussion

Abdominal pain is always a challenge for diagnosis and treatment in patients with SLE; it may be caused by the disease itself, other comorbidities or drug effects.1–3 The

involvement of gastrointestinal and hepatobiliary systems sparinggallbladderhavebeenreported.1–9Thedepositionof

immunecomplexesinbloodvesselwallsresultsinacute vas-culitis; these events result in ischemia and fibrosis in the targetorgan.4–9Thromboemboliceventsaremostfrequently

observedin patients withSLE; this risk isincreasedwhen anticardiolipinantibodyispositive,10asinthecaseof

anticar-diolipinIgM,anti-␤2glycoprotein1positive,althoughitwas alowtiter.Thepatientdoesnothavecriteriafordiagnosis ofantiphospholipidsyndrome.10Histologically,

antiphospho-lipidsyndrome ischaracterizedbymultiplethrombi inthe vesselsofthegallbladderwithoutevidenceofvasculite.5The

gallbladder is rarely involved in patients with SLE.1–9

Sev-eral casesofAAC as a complicationof SLEwere reported, butonlytwocasesofAACasaninitialmanifestationofSLE were described,onein apediatric patientand other in an adult.5,9Themostwidelyusedclassificationcriteriafor

diag-nosis of SLE are those proposed by the American College ofRheumatologyand SystemicLupusInternational Collab-oratingClinicsthatrequirefour ormoreitemstodiagnose SLE(cutaneous manifestation,joints, serositis, renal disor-der,hematologicdisorder,immunologicabnormality).11,12In

thiscase,thepatientpresentedwithpainintheperipheral joints,pleuralandpericardialeffusion,proteinuria,hemolytic anemia,leukopenia,positiveANA,positiveanti-dsDNA, posi-tiveanti-␤2glycoprotein1,positiveSmandlowcomplement. Whenthereisasuspicionofinvolvementofthegallbladder asthe cause ofabdominal paininthese patients, abdomi-nalultrasoundandcomputedtomography(CT)areindicated forbetterassessmentofAAC.13Inthiscase,theabdominal

ultrasound performed at admission was inconclusive. The abdominalCTperformedwasessentialforrevealingthe gall-bladder wall thickness withedema aroundthe gallbladder without the presenceofstones,important findingsfor the diagnosisofAACcasesthathavenotbeendisclosedbythe ultrasoundmadeintheadmission.Nootherriskfactorsfor cholecystitiswerefound.Inthiscase,AACmaybedueto mul-tiple thrombi in thegallbladder vessels.8 Thetreatmentof

AAChasbeencontroversial.Therearefourcasesreportedof patientswithAACinSLE,whichdidnothavecholecystectomy, and responded well to medicaltreatment with high doses of corticosteroid.4,5,7,9 In this case, due to major

improve-ment ofthe symptoms withantibiotics, corticosteroidwas started inoutpatientfollow-up.Surgerywasnotperformed whichjustifynohistologicaldescription.Highdosesof cor-ticosteroids are usuallysuggestedas first-line treatment if patientshaveagoodgeneralconditionwithoutother chole-cystitisriskfactors,noserioushealthcomplicationsandno infections.7

Conclusions

Despitetherarity,weshouldnotforgetthatacuteacalculous cholecystitis,besidesbeingacomplication,canbetheinitial manifestationofSLE.Conservativetreatmentshouldbe con-sidered.Inthiscase,corticosteroidwasstartedafterpatient discharge;itmadethiscaseunique.Computedtomographyis agoodexamforbetterassessmentofAAC.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

Acknowledgments

WewouldliketoacknowledgeDr.HumbertoMoraisandDra BrunaDavidforsuggestions.

r

e

f

e

r

e

n

c

e

s

1.TuY-T,YehK-W,ChenL-C,YaoT-C,OuL-S,LeeW-I,etal. Differencesindiseasefeaturesbetweenchildhood–onsetand adult–onsetinsystemiclupuserythematosuspatients presentingwithAcuteAbdominalPain.SeminArthritis Rheum.2011;40:447–54.

2.RicherO,UlinskiT,LemelleI,RanchinB,LoiratC,PietteJC, etal.Abdominalmanifestationsinchildhood–onsetsystemic lupuserythematosus.AnnRheumDis.2007;66:

174–8.

3.EbertEC,HagspielKD.Gastrointestinalandhepatic manifestationsofsystemiclupuserythematosus.JClin Gastroenterol.2011;45:436–41.

4.KamimmuraT,MimoriA,TakedaA,MasuyamaJ,YoshioT, OkazakiH,etal.Acuteacalculuoscholecystitisinsystemic lupuserythematosus.Lupus.1998;7:361–3.

5.Mendonc¸aJA,Marques-NetoJ,PrandoP,AppenzellerS.Acute acalculuoscholecystitisinjuvenilsystemiclupus

(4)

184

rev bras reumatol.2016;56(2):181–184

6. BasiratniaM,VaseiM,BahadorA,EbrahimE,DarakhshanA. Acuteacalculouscholecystitisinachildwithsystemiclupus erythematosus.PediatrNephrol.2006;21:873–6.

7. ShinSJ,NaKS,JungSS,BaeSC,YooDH,KimSY,etal.Acute acalculouscholecystitisassociatedwithsystemiclupus erythematosuswithSjogren’ssyndrome.KoreanJIntern Med.2002;17:61–4.

8. SwanepoelCR,FloydA,AllisonH,LearmonthGM,CassidyMJ, PascoeMD.Acuteacalculouscholecystitiscomplicating systemiclupuserythematosus:casereportandreview.Br MedJClinResEd.1983;286:251–2.

9. GhorbelIB,SouabniL,LamloumM,KhanfirM,BrahamA, MiledM,etal.Unecholécystiteaiguëalithiasiquerévélantun lupusérythémateuxsystémique.GastroenterolClinBiol. 2009;33:1175–8.

10.WilsonAW,GharaviAE,KoikeT,LockshinMD,BranchDW, PietteJC,etal.Internationalconsensusstatementon

preliminaryclassificationcriteriafordefinite

antiphospholipidsyndrome.Reportonaninternational workshop.ArthritisRheum.1999;42:

1309–11.

11.HochbergMC.UpdatingtheAmericanCollegeof Rheumatologyrevisedcriteriafortheclassificationof systemicLupuserythematosus.ArthritisRheum. 1997;40:1725.

12.PetriM,OrbaiAM,AlarconGS,GordonC,MerrillJT,FortinPR, etal.Derivationandvalidationofthesystemiclupus internationalcollaboratingclinicsclassificationcriteriafor systemiclupuserythematosus.ArthritisRheum.

2012;64:2677e86.

Imagem

Table 1 – Laboratory findings during admission course.
Fig. 1 – Abdominal CT show gallbladder wall thickness without stone with edema around (arrow).

Referências

Documentos relacionados

Perante o cenário apresentado, e como os consumos energéticos constam na matriz dos aspe- tos ambientais significativos consequentes das atividades da TORRESTIR, os últimos

Com essa classificação é possível perceber que o direito de todas as mulheres permanecerem com seus filhos durante o período de aleitamento em liberdade ou

Na verdade, o estudo pode permitir melhor compreender a influência da avaliação nos estados debilitantes de ansiedade vivenciados pelas futuras professoras em situação de

The monograph “New Trends in Tourism Research - A Polish Perspective” is just one of three outcomes of the II International Conference promoted in Poznan, Poland (19 th – 21 st May

The study was conducted by interviewing using a question- naire, in a sample consisting of 107 women (between 17 and 75 years), healthy, some with clinical signs of climacteric

Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.. Prevalence of atherosclerotic risk factors and

Conclusion: OA associated with obesity caused a negative impact on functional capacity; however, quality of life scores were low, and no difference in obese and non-obese subjects

Objectives: To describe the use of public resources to treat AS in a tertiary hospital after the use of biological medications was approved for treating spondyloarthritis in the